The pharmacologic basis for moxalactam therapy for gram-negative enteric bacillary meningitis of infancy.
D000818:Animals; D002511:Cephalosporins / Q000627:therapeutic use*; D002513:Cephamycins / Q000134:cerebrospinal fluid / Q000627:therapeutic use*; D004927:Escherichia coli Infections / Q000188:drug therapy; D008297:Male; D008581:Meningitis / Q000188:drug therapy* / Q000382:microbiology; D009070:Moxalactam; D011817:Rabbits
D002511:Cephalosporins; D002513:Cephamycins; D009070:Moxalactam